PRESS DIGEST- Financial Times - Jan. 4
- MGM Resorts, the U.S. casino company, has made a bid to buy the owner of British bookmaker Ladbrokes with the financial support of U.S. billionaire mogul Barry Diller's IAC group, said people briefed about the matter. - Italy's Angelini Pharma has agreed to buy emerging Swiss biotech company Arvelle Therapeutics for up to $960 million as it aims to become a leading European player in the treatment of central nervous system and mental diseases.
The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines
- Boris Johnson warns of tougher COVID-19 restrictions for England https://on.ft.com/2Lm3Vc0 - MGM bids to buy Ladbrokes owner Entain https://on.ft.com/388EjrO
- Italy's Angelini to buy Swiss biotech group for $1 bln https://on.ft.com/38aVNUI Overview
- Boris Johnson has put England on alert for tougher COVID-19 restrictions and possible further school closures as ministers raced to deploy a vaccine against the backdrop of a chaotic return to the classroom. - MGM Resorts, the U.S. casino company, has made a bid to buy the owner of British bookmaker Ladbrokes with the financial support of U.S. billionaire mogul Barry Diller's IAC group, said people briefed about the matter.
- Italy's Angelini Pharma has agreed to buy emerging Swiss biotech company Arvelle Therapeutics for up to $960 million as it aims to become a leading European player in the treatment of central nervous system and mental diseases. (Compiled by Bengaluru newsroom)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- European
- British
- Boris Johnson
- Swiss
ALSO READ
European stocks rise ahead of inflation data; Basilea shines
European stocks rise ahead of inflation data; Basilea shines
Cyclicals drive modest gains across European stocks
Israel passes new environmental law adopting European standards for industries
UPDATE 1-European shares slide to two-week low on hawkish Fed comments, geopolitical worries